1. Home
  2. DAO vs AGIO Comparison

DAO vs AGIO Comparison

Compare DAO & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youdao Inc. each representing one

DAO

Youdao Inc. each representing one

HOLD

Current Price

$14.66

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$32.92

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAO
AGIO
Founded
2006
2007
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
DAO
AGIO
Price
$14.66
$32.92
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $38.88
AVG Volume (30 Days)
63.2K
★ 736.0K
Earning Date
05-28-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $43,011,000.00
Revenue This Year
$12.24
$76.75
Revenue Next Year
$14.60
$170.73
P/E Ratio
$72.35
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$22.24
52 Week High
$18.94
$46.00

Technical Indicators

Market Signals
Indicator
DAO
AGIO
Relative Strength Index (RSI) 45.76 44.44
Support Level $9.57 $32.43
Resistance Level $18.79 $35.88
Average True Range (ATR) 0.67 1.37
MACD 0.02 -0.01
Stochastic Oscillator 68.69 33.46

Price Performance

Historical Comparison
DAO
AGIO

About DAO Youdao Inc. each representing one

Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: